Search Results 351-360 of 17060 for ✔

1. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Regorafenib is a type of drug called a kinase inhibitor. Regorafenib interferes with how some kinase proteins work. Some of these kinases in cancer cells might ...

2. A Study to Evaluate the Safety and Effectiveness of Gantenerumab in Participants With Early Alzheimer's Disease (AD) - Mayo Clinic

   All participants must show evidence of beta-amyloid pathology. Eligible participants will be randomized 1:1 to receive either subcutaneous (SC) injection of ...

3. Adrenocortical Carcinoma in Children - Mayo Clinic

   Limited evidence exists on a definite histopathological criterion to differentiate ACC from adrenocortical adenomas. Early diagnosis and management is the key.

4. Efficacy And Safety Of Nintedanib In Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) - Mayo Clinic

   There is currently no efficacious treatment available for PF-ILD. Based on its efficacy and safety in Idiopatic Pulmonary Fibrosis (IPF), it is anticipated that ...

5. Using a Digital Phenotype in the Diagnosis and Prediction of Outcomes in Cirrhosis - Mayo Clinic

   The purpose of this study is to define a comprehensive digital phenotype through radio signal-enabled passive environment monitoring, associated with clinical ...

6. A Study to Evaluate the Safety and Diagnostic Effectiveness of Mangoral in Patients With Focal Liver Lesions and Reduced Kidney Function - Mayo Clinic

   The diagnostic efficacy of Mangoral will be assessed in terms of visualization of detected focal liver lesions in combined MRI (CMRI: combined Mangoral-enhanced ...

7. Mirroring Success at Mayo Clinic Through Mentorship: The Sky's The Limit - News Archive

   In this article series, Ph.D. mentees and their mentors at Mayo Clinic College of Medicine and Science testify to the power of mentorship.

8. Performance Of A Multi-Target Hepatocellular Carcinoma (HCC) Test In Subjects With Increased Risk - Mayo Clinic

   About this study. The primary objective of this study is to assess overall sensitivity and specificity of Oncoguard™ Liver for hepatocellular cancer (HCC) ...

9. Maternal-Infant Haplotypes and Tissue Rejection Pathways in Placental Villitis Examination - Mayo Clinic

   The purpose of this study is to identify genetic and molecular signatures of Villitis of Unknown Etiology (VUE) related to disease severity and poor pregnancy/ ...

10. HIV/AIDS - Doctors and departments - Mayo Clinic

    Learn more about this potentially life-threatening infection that spreads through blood, sex and childbirth. Know how to prevent and treat it.